» Articles » PMID: 38281136

Heterologous Sarbecovirus Receptor Binding Domains As Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation

Abstract

Structure-guided rational immunogen design can generate optimized immunogens that elicit a desired humoral response. Design strategies often center on targeting conserved sites on viral glycoproteins that will ultimately confer potent neutralization. For SARS-CoV-2 (SARS-2), the surface-exposed spike glycoprotein includes a broadly conserved portion, the receptor binding motif (RBM), that is required to engage the host cellular receptor, ACE2. Expanding humoral responses to this site may result in a more potent neutralizing antibody response against diverse sarbecoviruses. Here, we used a "resurfacing" approach and iterative design cycles to graft the SARS-2 RBM onto heterologous sarbecovirus scaffolds. The scaffolds were selected to vary the antigenic distance relative to SARS-2 to potentially focus responses to RBM. Multimerized versions of these immunogens elicited broad neutralization against sarbecoviruses in the context of preexisting SARS-2 immunity. These validated engineering approaches can help inform future immunogen design efforts for sarbecoviruses and are generally applicable to other viruses.

References
1.
Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

2.
Pinto D, Park Y, Beltramello M, Walls A, Tortorici M, Bianchi S . Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020; 583(7815):290-295. DOI: 10.1038/s41586-020-2349-y. View

3.
Cohen A, Gnanapragasam P, Lee Y, Hoffman P, Ou S, Kakutani L . Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science. 2021; 371(6530):735-741. PMC: 7928838. DOI: 10.1126/science.abf6840. View

4.
Garcia-Beltran W, Lam E, Astudillo M, Yang D, Miller T, Feldman J . COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021; 184(2):476-488.e11. PMC: 7837114. DOI: 10.1016/j.cell.2020.12.015. View

5.
Wec A, Wrapp D, Herbert A, Maurer D, Haslwanter D, Sakharkar M . Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science. 2020; 369(6504):731-736. PMC: 7299279. DOI: 10.1126/science.abc7424. View